Bionuclex Research

Bionuclex Research is a Cape Town-based biotechnology facility specializing in biomarker discovery, translational research, and computational bioinformatics. The company bridges the gap between clinical research and patient care by leveraging machine learning, AI, and integrated systems biology to analyze omics and wet-lab data. Their platform focuses on identifying actionable insights to accelerate the development of diagnostic tools, with a particular emphasis on addressing genomic diversity and improving disease detection for African populations. By streamlining study planning and data generation, they aim to reduce the timeline for bringing scientific research to practical medical application.

For researchers and partners, Bionuclex provides end-to-end support ranging from analytical study planning and sample acquisition to high-quality data analysis. The company addresses critical challenges in healthcare, such as the lack of representative data in global AI health applications, by fostering strategic partnerships and applying unique perspectives to clinical innovation. Their expertise in liquid biomarker analysis—including protein marker screening and RNA analysis—supports diagnostic research for various cancer types, including breast, prostate, and colorectal cancers. Through their interdisciplinary approach, they help translate complex laboratory findings into real-world, impactful clinical solutions.